Over 100 academics, psychologists, anthropologists and activists have signed a manifesto launched by the Chacruna Institute for Psychedelic Plant Medicines calling for an end to police...
PharmaDrug Inc.
By combining AI, clinical testing and computer analysis of vast amounts of biomedical knowledge and electronic health records, researchers at Case Western Reserve University have found...
Awakn Life Sciences has signed its first Licensing Partnership agreement in Europe with a healthcare consortium.
In two letters seen by Psychedelic Health, a cross-party group of MEPs has expressed concern over the lack of progress with the medical use of psychedelics...
Doug Drysdale, CEO of Cybin Inc.,
In what marks a significant finding in the advancement of psychedelic research, a new study has demonstrated that the location of serotonin 2A receptors (5-HT2A) is...
LongeVC has invested in psychedelics startup Freedom Biosciences which is pioneering the use of ketamine and other compounds in next-generation treatments.
Reset Mind Sciences, a wholly-owned subsidiary of Little Green Pharma, has received Human Research Ethics Committee (HREC) approval for a trial investigating psilocybin-assisted psychotherapy for the...
In what marks an important development for Europe, a number of EU bodies have published a joint commentary in the world-leading medical journal, The Lancet, acknowledging...